Showing 4,861 - 4,880 results of 5,484 for search '"pharmaceutical"', query time: 0.10s Refine Results
  1. 4861
  2. 4862
  3. 4863
  4. 4864

    Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity by Andrew Overholser, Eric Czech, Linda Speer, Joel Wilson, Alex Overholser

    Published 2025-02-01
    “…The current United States Food and Drug Administration (FDA) approved pharmaceutical therapy choices for long-term use include a combination of phentermine-topiramate, combination bupropion-naltrexone, orlistat, glucagon-like peptide-1 receptor agonists (GLP-1RAs), and dual action GLP-1RAs and gastric inhibitory peptide agonists (GIP). …”
    Get full text
    Article
  5. 4865
  6. 4866
  7. 4867
  8. 4868
  9. 4869
  10. 4870
  11. 4871
  12. 4872
  13. 4873

    The South African guidelines on enuresis: 2024 update by A Adam, A Badenhorst, F Claassen, T de Maayer, M Fockema, J Fredericks, E Gottlich, J John, N Lala, J Lazarus, S Leahy, H N Lourens, S Maharaj, K M Mathabe, E M Moshokoa, S B A Mutambirwa, K L Petersen, M B Radzuma, A van der Merwe, I van Heerden, C A Zietsman, F Alyami, A Deshpande, G H H Smith

    Published 2024-11-01
    “…These options include behavioural modification, urotherapy, pharmaceutical therapy, alarm therapy, alternative therapies, neuromodulation, psychological support and biofeedback. …”
    Get full text
    Article
  14. 4874
  15. 4875
  16. 4876
  17. 4877
  18. 4878
  19. 4879

    An integrative analysis reveals cancer risk associated with artificial sweeteners by Jumin Xie, Ying Zhu, Zixuan Yang, Zhang Yu, Mingzhi Yang, Qingzhi Wang

    Published 2025-01-01
    “…Abstract Background Artificial sweeteners (AS) have been widely utilized in the food, beverage, and pharmaceutical industries for decades. While numerous publications have suggested a potential link between AS and diseases, particularly cancer, controversy still surrounds this issue. …”
    Get full text
    Article
  20. 4880